The FDA has recently approved an innovative new drug called Syfovre™, which marks a major breakthrough in the treatment of dry age-related macular degeneration (AMD). Syfovre™ is an eye injection used to treat geographic atrophy (GA), also known as the the advanced form of dry AMD. This groundbreaking new treatment has the potential to prevent blindness in millions of Americans who would otherwise lose their sight to this progressive disease. RAWNY is pleased to offer Syfovre™ as a treatment for dry AMD for qualifying patients.
What is Geographic Atrophy?
Click here to learn what GA is and how it can lead to vision loss.
What is Syfovre?
Learn more about the recent FDA-approval of Syfovre, the first treatment for GA secondary to dry AMD.
Schedule a Dry AMD Consultation
Schedule an appointment with one of our retina specialists to see if you may qualify for a dry AMD treatment.
Low Vision Services
Click here to learn about how low vision rehabilitation services may help those with GA or other retinal conditions.
Dry AMD Treatment Financial Assistance
Here you will find patient assistance and support programs for dry AMD treatments.
RAWNY is pleased to offer bulk eye vitamins that help slow the progression of AMD.